XML 31 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated statements of comprehensive loss - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Consolidated statements of comprehensive loss      
Revenue € 47,473 € 42,234 € 38,453
Cost of sales 27,712 28,735 35,286
Gross profit 19,761 13,499 3,167
Research and development expenses 17,488 19,297 14,935
General administrative expenses 32,587 43,480 37,665
Selling expenses 9,924 9,326 7,580
Impairment of financial assets   827 3,636
Gain on reversal of financial asset impairment 432    
Other operating income 3,774 2,894 2,392
Other operating expenses 741 86 182
Operating loss (36,773) (56,623) (58,439)
Changes in fair value of warrants 2,574    
Interest and similar income 512 3 6
Interest and similar expenses 4,909 802 1,381
Financial costs, net (1,823) (799) (1,375)
Loss before taxes from continuing operations (38,596) (57,422) (59,814)
Income taxes expenses 107 (70) 224
Loss for the year from continuing operations (38,703) (57,352) (60,038)
Net income from discontinued operations, net of tax 6,862 11,106 38,052
Loss for the period (31,841) (46,246) (21,986)
Other comprehensive income/(loss), all attributable to equity holders of the parent (76) 543 (48)
Total comprehensive loss (31,917) (45,703) (22,034)
Attributable to:      
Equity holders of the parent (31,917) (45,801) (22,094)
Non-controlling interests from continuing operations   98 60
Total comprehensive loss € (31,917) € (45,703) € (22,034)
Net loss per share - Continuing operations - Basic (in EUR) € (1.45) € (2.53) € (2.87)
Net loss per share - Continuing operations - Diluted (in EUR) (1.45) (2.53) (2.87)
Net loss per share - Loss attributable to parent - Basic (in EUR) (1.19) (2.04) (1.05)
Net loss per share - Loss attributable to parent - Diluted (in EUR) € (1.19) € (2.04) € (1.05)